Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in Ann Intern Med Retrieve available abstracts of 157 articles: HTML format

Single Articles

March 2021
1. NANNA MG, Newby LK
   In coronary artery disease, PCI increases all-cause and cause-specific mortality compared with CABG.
   Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
   PubMed     Abstract available
   
   
   
2. BATES ER
   In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes.
   Ann Intern Med. 2021;174:JC30.
   PubMed     Abstract available
   
   
   
3. GIANNASI G, Nanni V, Nucci A, Perini AP, et al
   Acute ST-Segment Elevation From an Ingested Battery: A Case Report.
   Ann Intern Med. 2021;174:425-426.
   PubMed    
   
   
   January 2021
4. COHN JN
   Low-dose colchicine reduced risk for cardiovascular events in chronic coronary disease.
   Ann Intern Med. 2021 Jan 5. doi: 10.7326/ACPJ202101190.
   PubMed     Abstract available
   
   
   December 2020
5. HICKS CW, Wang D, Matsushita K, Windham BG, et al
   Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.
   Ann Intern Med. 2020 Dec 8. doi: 10.7326/M20-1340.
   PubMed     Abstract available
   
   
   October 2020
6. BAVISHI C
   In ACS treated with drug-eluting stents and 3 mo of DAPT, ticagrelor monotherapy reduced clinical events at 1 y vs. DAPT.
   Ann Intern Med. 2020;173:JC43.
   PubMed     Abstract available
   
   
   
7. NANNA MG, Granger CB
   In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel.
   Ann Intern Med. 2020;173:JC44.
   PubMed     Abstract available
   
   
   September 2020
8. RESTON JT, Buelt A, Donahue MP, Neubauer B, et al
   Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia.
   Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4680.
   PubMed     Abstract available
   
   
   
9. O'MALLEY PG, Arnold MJ, Kelley C, Spacek L, et al
   Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
   Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4648.
   PubMed     Abstract available
   
   
   
10. KELSEY MD, Newby LK
    In older patients with NSTE-ACS, clopidogrel safely reduced bleeding compared with ticagrelor at 1 year.
    Ann Intern Med. 2020;173:JC28.
    PubMed     Abstract available
    
    
    
11. HOFFER EP
    In AF with recent ACS or PCI, apixaban improved 30-day outcomes vs. VKAs; aspirin effects varied vs. placebo.
    Ann Intern Med. 2020;173:JC29.
    PubMed     Abstract available
    
    
    
12. ELGENDY IY
    In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding.
    Ann Intern Med. 2020;173:JC27.
    PubMed     Abstract available
    
    
    
13. D'ANCI KE, Tipton K, Hedden-Gross A, Rouse B, et al
    Effect of Intensive Blood Pressure Lowering on Cardiovascular Outcomes: A Systematic Review Prepared for the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Guidelines.
    Ann Intern Med. 2020 Sep 1. doi: 10.7326/M20-2037.
    PubMed     Abstract available
    
    
    August 2020
14. MACINTYRE CR
    Influenza Vaccine: Routine Secondary Prevention for Patients With Cardiovascular Disease?
    Ann Intern Med. 2020 Aug 25. doi: 10.7326/M20-5810.
    PubMed    
    
    
    
15. CHOW EJ, Rolfes MA, O'Halloran A, Anderson EJ, et al
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults : A Cross-sectional Study.
    Ann Intern Med. 2020 Aug 25. doi: 10.7326/M20-1509.
    PubMed     Abstract available
    
    
    
16. BATES ER
    In stable coronary disease with moderate or severe ischemia, initial invasive therapy plus medical therapy did not improve CV outcomes at 3 years.
    Ann Intern Med. 2020;173:JC14.
    PubMed     Abstract available
    
    
    
17. BATES ER
    Invasive therapy improved angina health status in patients with high-risk stable coronary disease and more frequent angina.
    Ann Intern Med. 2020;173:JC15.
    PubMed     Abstract available
    
    
    
18. HERRINGTON WG, Staplin N
    In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes.
    Ann Intern Med. 2020;173:JC16.
    PubMed     Abstract available
    
    
    
19. HERRINGTON WG, Staplin N
    In patients with coronary disease and CKD, initial invasive therapy did not improve angina-related health status.
    Ann Intern Med. 2020;173:JC17.
    PubMed     Abstract available
    
    
    July 2020
20. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Coronary Artery Calcium Score: Chalk or Cheese?
    Ann Intern Med. 2020;173:CG1.
    PubMed    
    
    
    
21. MENICHELLI M, Neumann FJ, Ndrepepa G, Mayer K, et al
    Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes: Results From a Randomized Trial.
    Ann Intern Med. 2020 Jul 21. doi: 10.7326/M20-1806.
    PubMed     Abstract available
    
    
    
22. CONEN D, Md PJD
    The Value of Large Randomized Trials of Two Active Interventions to Define the Optimal Treatment in Patients With Acute Coronary Syndrome.
    Ann Intern Med. 2020 Jul 21. doi: 10.7326/M20-4770.
    PubMed    
    
    
    
23. 
    Correction: Annals Consult Guys - Preventing Coronary Disease in Rheumatoid Arthritis: Do Guidelines Apply?
    Ann Intern Med. 2020;173:79.
    PubMed    
    
    
    
24. KIM JH, Hammadah M, Vaccarino V, Quyyumi AA, et al
    High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients.
    Ann Intern Med. 2020;173:76-77.
    PubMed    
    
    
    
25. WALTER J, Mueller C
    High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients.
    Ann Intern Med. 2020;173:77.
    PubMed    
    
    
    June 2020
26. DUCEPPE E, Heels-Ansdell D, Devereaux PJ
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery.
    Ann Intern Med. 2020;172:843.
    PubMed    
    
    
    
27. GUPTA N, Doshi R, Meghrajani V
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery.
    Ann Intern Med. 2020;172:842.
    PubMed    
    
    
    
28. BHUDIA N, Bakhai A, Baumber R
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery.
    Ann Intern Med. 2020;172:842-843.
    PubMed    
    
    
    
29. MURRAY H, Slaunwhite E
    Accelerated diagnostic algorithms with hs-cTn have >/= 92% sensitivity but lower specificity for diagnosing AMI.
    Ann Intern Med. 2020;172:JC71.
    PubMed     Abstract available
    
    
    May 2020
30. FINUCANE TE
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2020;172:707.
    PubMed    
    
    
    
31. PARK S, Han K, Kim DK
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2020;172:707-708.
    PubMed    
    
    
    
32. VALLABHAJOSYULA S, Bell MR
    In unprotected left main CAD, revascularization with PCI and DES increased risk for MACCE vs CABG at 5 years.
    Ann Intern Med. 2020;172:JC55.
    PubMed     Abstract available
    
    
    April 2020
33. BACH RG
    Low-dose colchicine after MI reduced a composite ischemic cardiovascular outcome vs placebo.
    Ann Intern Med. 2020;172:JC39.
    PubMed    
    
    
    March 2020
34. KLOECKER DE, Davies MJ, Khunti K, Zaccardi F, et al
    Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes.
    Ann Intern Med. 2020 Mar 24. pii: 2763641. doi: 10.7326/M19-3286.
    PubMed     Abstract available
    
    
    
35. VALLURUPALLI M, MacFadyen JG, Glynn RJ, Thuren T, et al
    Effects of Interleukin-1beta Inhibition on Incident Anemia: Exploratory Analyses From a Randomized Trial.
    Ann Intern Med. 2020 Mar 24. pii: 2763494. doi: 10.7326/M19-2945.
    PubMed     Abstract available
    
    
    
36. KHAN SU, Osman M, Khan MU, Khan MS, et al
    Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2020 Mar 17. pii: 2763089. doi: 10.7326/M19-3763.
    PubMed     Abstract available
    
    
    
37. DOHERTY JU
    Combined Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Navigating Between Scylla and Charybdis.
    Ann Intern Med. 2020 Mar 17. pii: 2763091. doi: 10.7326/M20-0572.
    PubMed    
    
    
    January 2020
38. RANASINGHE I, Hossain S, Ganesan A, Krumholz HM, et al
    Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation.
    Ann Intern Med. 2020;172:166-167.
    PubMed    
    
    
    
39. EMAMI M, Wong CX, Tu S, Sanders P, et al
    Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation.
    Ann Intern Med. 2020;172:166.
    PubMed    
    
    
    
40. SANTULLI G
    In AF and stable CAD, rivaroxaban reduced cardiovascular events and mortality more than rivaroxaban plus an antiplatelet.
    Ann Intern Med. 2020;172:JC6.
    PubMed    
    
    
    
41. HUDSON M
    In suspected AMI, an extended algorithm increased sensitivity and decreased specificity for predicting 30-day MACE.
    Ann Intern Med. 2020;172:JC11.
    PubMed    
    
    
    
42. RACO DL
    In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y.
    Ann Intern Med. 2020;172:JC5.
    PubMed    
    
    
    
43. RACO DL
    In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding.
    Ann Intern Med. 2020;172:JC4.
    PubMed    
    
    
    
44. CORNELL JE, Mulrow CD
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:75.
    PubMed    
    
    
    
45. MAYER M
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:74.
    PubMed    
    
    
    
46. KIVELA JM
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:73-74.
    PubMed    
    
    
    
47. BELL KJL, Semsarian C, Doust J
    Why We Might Not Need to Stress About Ruling Out Inducible Myocardial Ischemia.
    Ann Intern Med. 2020 Jan 7. pii: 2758510. doi: 10.7326/M19-3731.
    PubMed    
    
    
    
48. WALTER J, du Fay de Lavallaz J, Koechlin L, Zimmermann T, et al
    Using High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients: A Cohort Study.
    Ann Intern Med. 2020 Jan 7. pii: 2758509. doi: 10.7326/M19-0080.
    PubMed     Abstract available
    
    
    December 2019
49. DUCEPPE E, Patel A, Chan MTV, Berwanger O, et al
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery: A Cohort Study.
    Ann Intern Med. 2019 Dec 24. pii: 2758032. doi: 10.7326/M19-2501.
    PubMed     Abstract available
    
    
    
50. QAMAR A, Bangalore S
    Biomarkers to Personalize Preoperative Cardiovascular Risk Stratification: Ready for Prime Time?
    Ann Intern Med. 2019 Dec 24. pii: 2758034. doi: 10.7326/M19-3718.
    PubMed    
    
    
    
51. 
    Correction: Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2019 Dec 17. pii: 2757635. doi: 10.7326/L19-0721.
    PubMed    
    
    
    
52. DODSON JA, Hajduk AM, Geda M, Krumholz HM, et al
    Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study.
    Ann Intern Med. 2019 Dec 10. pii: 2757402. doi: 10.7326/M19-0974.
    PubMed     Abstract available
    
    
    
53. KAZI DS, Bibbins-Domingo K
    Accurately Predicting Cardiovascular Risk-and Acting on It.
    Ann Intern Med. 2019 Dec 10. pii: 2757420. doi: 10.7326/M19-3662.
    PubMed    
    
    
    
54. DOXEY R
    Stable Ischemic Heart Disease.
    Ann Intern Med. 2019;171:862-863.
    PubMed    
    
    
    November 2019
55. PARK S, Lee S, Kim Y, Lee Y, et al
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status: A Nationwide Population-Based Study of Approximately 10 Million Persons.
    Ann Intern Med. 2019 Nov 26. pii: 2756142. doi: 10.7326/M19-0563.
    PubMed     Abstract available
    
    
    
56. 
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2019 Nov 26. pii: 2756144. doi: 10.7326/P19-0016.
    PubMed    
    
    
    
57. CHESKIN LJ, Slavin M
    Review: No high-certainty evidence exists that nutritional supplements or diets affect cardiovascular outcomes.
    Ann Intern Med. 2019;171:JC50.
    PubMed    
    
    
    October 2019
58. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Preventing Coronary Disease in Rheumatoid Arthritis: Do Guidelines Apply?
    Ann Intern Med. 2019;171:CG1.
    PubMed    
    
    
    
59. COHEN JB, Denker MG, Cohen DL, Townsend RR, et al
    Cardiovascular Events and Mortality in White Coat Hypertension.
    Ann Intern Med. 2019;171:603-604.
    PubMed    
    
    
    
60. ZHANG ZY, Asayama K, Franklin SS, Thijs L, et al
    Cardiovascular Events and Mortality in White Coat Hypertension.
    Ann Intern Med. 2019;171:602-603.
    PubMed    
    
    
    
61. BELLO NA, Miller EC, Cleary KL, Wapner R, et al
    Cases in Precision Medicine: A Personalized Approach to Stroke and Cardiovascular Risk Assessment in Women.
    Ann Intern Med. 2019 Oct 15. pii: 2753022. doi: 10.7326/M19-1601.
    PubMed     Abstract available
    
    
    
62. BATES ER
    In patients with suspected AMI and LBBB, algorithms based on ECG and troponin data were tested to rule MI in or out.
    Ann Intern Med. 2019;171:JC47.
    PubMed    
    
    
    
63. BATES ER
    In suspected MI without ST elevation, a risk tool including hs-cTnI or hs-cTnT predicted diagnosis and 30-d outcomes.
    Ann Intern Med. 2019;171:JC46.
    PubMed    
    
    
    September 2019
64. SELAK V, Jackson R, Poppe K, Wu B, et al
    Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis.
    Ann Intern Med. 2019 Sep 17. pii: 2751452. doi: 10.7326/M19-1132.
    PubMed     Abstract available
    
    
    August 2019
65. KATZ D, Gavin MC
    Stable Ischemic Heart Disease.
    Ann Intern Med. 2019;171:ITC17-ITC32.
    PubMed     Abstract available
    
    
    July 2019
66. RANASINGHE I, Labrosciano C, Horton D, Ganesan A, et al
    Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation: A Cohort Study.
    Ann Intern Med. 2019 Jul 30. pii: 2739788. doi: 10.7326/M18-2810.
    PubMed     Abstract available
    
    
    
67. O'BRIEN CW, Juraschek SP, Wee CC
    Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey.
    Ann Intern Med. 2019 Jul 23. pii: 2738925. doi: 10.7326/M19-0953.
    PubMed    
    
    
    
68. VALLABHAJOSYULA S, Bell MR
    Immediate and delayed coronary angiography did not differ for survival after OHCA without STEMI.
    Ann Intern Med. 2019;171:JC4.
    PubMed    
    
    
    
69. PANAGIOTOU OA, Kumar A, Gutman R, Keohane LM, et al
    Hospital Readmission Rates in Medicare Advantage and Traditional Medicare: A Retrospective Population-Based Analysis.
    Ann Intern Med. 2019;171:99-106.
    PubMed     Abstract available
    
    
    
70. KHAN SU, Khan MU, Riaz H, Valavoor S, et al
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence Map.
    Ann Intern Med. 2019 Jul 9. pii: 2737825. doi: 10.7326/M19-0341.
    PubMed     Abstract available
    
    
    
71. YEBYO HG, Aschmann HE, Puhan MA
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:74-76.
    PubMed    
    
    
    
72. DJULBEGOVIC B, Hozo I
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:73-74.
    PubMed    
    
    
    
73. ZHOU Z
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:73.
    PubMed    
    
    
    
74. SPENCE JD
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:72-73.
    PubMed    
    
    
    
75. SORUM PC
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:74.
    PubMed    
    
    
    
76. GOOD CB, Hernandez I, Parekh N
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:72.
    PubMed    
    
    
    June 2019
77. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Length of Stay After Myocardial Infarction: How Low Can We Go?
    Ann Intern Med. 2019;170:CG1.
    PubMed    
    
    
    
78. CENTOR RM, Blaha MJ
    Web Exclusive. Annals On Call - Coronary Artery Calcium Testing.
    Ann Intern Med. 2019;170:OC1.
    PubMed    
    
    
    
79. BATES ER
    After an acute coronary syndrome, alirocumab reduced total nonfatal CV events and deaths vs placebo.
    Ann Intern Med. 2019;170:JC62.
    PubMed    
    
    
    
80. KIRSCHNER JM, Hunter BR
    In normoxemic suspected MI, oxygen therapy did not reduce all-cause mortality or HF hospitalization at 2 years.
    Ann Intern Med. 2019;170:JC63.
    PubMed    
    
    
    
81. COHEN JB, Lotito MJ, Trivedi UK, Denker MG, et al
    Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2019 Jun 11. pii: 2735719. doi: 10.7326/M19-0223.
    PubMed     Abstract available
    
    
    
82. GRUNDY SM, Stone NJ
    2018 Cholesterol Clinical Practice Guidelines: Synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety Cholesterol Guideline.
    Ann Intern Med. 2019;170:779-783.
    PubMed     Abstract available
    
    
    May 2019
83. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Cardiovascular Risk, Blood Pressure, and Cognition in a Patient With Diabetes.
    Ann Intern Med. 2019;170:CG1.
    PubMed    
    
    
    
84. SCHECTMAN JM
    Review: In adults, general health checks do not reduce all-cause, cardiovascular, or cancer mortality.
    Ann Intern Med. 2019;170:JC52.
    PubMed    
    
    
    April 2019
85. BRAND A, Gao L, Hamann A, Crayen C, et al
    Medical Graphic Narratives to Improve Patient Comprehension and Periprocedural Anxiety Before Coronary Angiography and Percutaneous Coronary Intervention: A Randomized Trial.
    Ann Intern Med. 2019 Apr 9. pii: 2730521. doi: 10.7326/M18-2976.
    PubMed    
    
    
    March 2019
86. AVIV A
    Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer.
    Ann Intern Med. 2019;170:356.
    PubMed    
    
    
    
87. O'GLASSER AY
    Regarding Marcia.
    Ann Intern Med. 2019;170:346-347.
    PubMed    
    
    
    February 2019
88. SELAK V, Jackson R, Poppe K, Wu B, et al
    Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Cohort Study.
    Ann Intern Med. 2019 Feb 26. pii: 2726667. doi: 10.7326/M18-2808.
    PubMed     Abstract available
    
    
    
89. LU J, Lu Y, Yang H, Bilige W, et al
    Characteristics of High Cardiovascular Risk in 1.7 Million Chinese Adults.
    Ann Intern Med. 2019 Feb 19. pii: 2725144. doi: 10.7326/M18-1932.
    PubMed     Abstract available
    
    
    
90. WHELTON PK, Colantonio LD
    Cardiovascular Disease Risk Estimation in China.
    Ann Intern Med. 2019 Feb 19. pii: 2725146. doi: 10.7326/M18-3301.
    PubMed    
    
    
    
91. BELL KJL, Doust J, Glasziou P, Cullen L, et al
    Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example?
    Ann Intern Med. 2019;170:259-261.
    PubMed    
    
    
    
92. KAZI DS, Penko J, Coxson PG, Guzman D, et al
    Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.
    Ann Intern Med. 2019;170:221-229.
    PubMed     Abstract available
    
    
    
93. CARDOSO R, Nasir K, Blumenthal RS, Blaha MJ, et al
    Selective Use of Coronary Artery Calcium Testing for Shared Decision Making: Guideline Endorsed and Ready for Prime Time.
    Ann Intern Med. 2019 Feb 12. pii: 2724340. doi: 10.7326/M18-3675.
    PubMed    
    
    
    January 2019
94. JORGE A, Wallace ZS, Lu N, Zhang Y, et al
    Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study.
    Ann Intern Med. 2019 Jan 22. pii: 2722549. doi: 10.7326/M18-1570.
    PubMed     Abstract available
    
    
    
95. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Low Risk for Postoperative Myocardial Infarction: What Do We Really Know?
    Ann Intern Med. 2019;170:CG1.
    PubMed    
    
    
    
96. GOODMAN M, Getahun D, Silverberg MJ, Safer J, et al
    Cross-Sex Hormones and Acute Cardiovascular Events in Transgender Persons.
    Ann Intern Med. 2019;170:143.
    PubMed    
    
    
    
97. GOLDSTEIN Z, Streed C, Resiman T, Mukherjee M, et al
    Cross-Sex Hormones and Acute Cardiovascular Events in Transgender Persons.
    Ann Intern Med. 2019;170:142-143.
    PubMed    
    
    
    
98. FURLAN S, Borzak S
    After PCI with 2nd-generation DESs for STEMI, dual-antiplatelet therapy for 6 mo was noninferior to 12 mo.
    Ann Intern Med. 2019;170:JC6.
    PubMed    
    
    
    
99. SULLIVAN K, Van Spall HGC
    A wearable cardioverter-defibrillator did not reduce arrhythmic death in MI with reduced ejection fraction.
    Ann Intern Med. 2019;170:JC5.
    PubMed    
    
    
    
100. THOMAS NJ
     Physician, Heal Thyself.
     Ann Intern Med. 2019;170:135.
     PubMed    
     
     
     
101. KAUFMAN TM, Fazio S, Shapiro MD
     Brief Commentary: Marijuana and Cardiovascular Disease-What Should We Tell Patients?
     Ann Intern Med. 2019 Jan 8. pii: 2720158. doi: 10.7326/M18-3009.
     PubMed    
     
     
     December 2018
102. HUDSON MP
     Coronary CTA reduced risk for coronary events at 5 years in patients with stable chest pain.
     Ann Intern Med. 2018;169:JC70.
     PubMed    
     
     
     
103. GILBERT MP, Bain SC, Franek E, Jodar-Gimeno E, et al
     Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial.
     Ann Intern Med. 2018 Dec 4. pii: 2717732. doi: 10.7326/M18-1569.
     PubMed    
     
     
     
104. YEBYO HG, Aschmann HE, Puhan MA
     Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
     Ann Intern Med. 2018 Dec 4. pii: 2717730. doi: 10.7326/M18-1279.
     PubMed     Abstract available
     
     
     
105. 
     Benefits and Harms of Using Statins to Prevent Cardiovascular Disease.
     Ann Intern Med. 2018 Dec 4. pii: 2717123. doi: 10.7326/P18-0019.
     PubMed    
     
     
     November 2018
106. BATES ER
     Review: In coronary artery disease, PCI reduces 30-day and 5-year risk for stroke compared with CABG.
     Ann Intern Med. 2018;169:JC55.
     PubMed    
     
     
     
107. SMITH DA
     Review: In adults, increasing omega-6 fatty acid intake does not reduce mortality or overall cardiovascular events.
     Ann Intern Med. 2018;169:JC51.
     PubMed    
     
     
     
108. SMITH DA
     Review: Long-chain omega-3 fatty acids have no effect on mortality or overall cardiovascular events.
     Ann Intern Med. 2018;169:JC50.
     PubMed    
     
     
     
109. CENTOR RM, Hayward RA
     Web Exclusive. Annals On Call - Improving Estimation of Cardiovascular Risk.
     Ann Intern Med. 2018;169:OC1.
     PubMed    
     
     
     
110. DEVEREAUX PJ
     The Potential for Troponin to Inform Prognosis in Patients With Stable Coronary Artery Disease.
     Ann Intern Med. 2018 Nov 6. pii: 2712931. doi: 10.7326/M18-2984.
     PubMed    
     
     
     
111. HAMMADAH M, Kim JH, Tahhan AS, Kindya B, et al
     Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study.
     Ann Intern Med. 2018 Nov 6. pii: 2712482. doi: 10.7326/M18-0670.
     PubMed     Abstract available
     
     
     October 2018
112. GROSSO G, Sippl N, Kjellstrom B, Amara K, et al
     Antiphospholipid Antibodies in Patients With Myocardial Infarction.
     Ann Intern Med. 2018 Oct 23. pii: 2709123. doi: 10.7326/M18-2130.
     PubMed    
     
     
     August 2018
113. 
     Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors.
     Ann Intern Med. 2018;169:270-271.
     PubMed    
     
     
     
114. MAI LM, Oczkowski W
     Tenecteplase before thrombectomy for ischemic stroke improved reperfusion compared with alteplase.
     Ann Intern Med. 2018;169:JC20.
     PubMed    
     
     
     July 2018
115. LIU P, Dhruva SS, Shah ND, Ross JS, et al
     Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs.
     Ann Intern Med. 2018 Jul 24. pii: 2694805. doi: 10.7326/M18-0965.
     PubMed    
     
     
     
116. GETAHUN D, Nash R, Flanders WD, Baird TC, et al
     Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
     Ann Intern Med. 2018 Jul 10. pii: 2687653. doi: 10.7326/M17-2785.
     PubMed     Abstract available
     
     
     
117. STUART JJ, Tanz LJ, Missmer SA, Rimm EB, et al
     Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study.
     Ann Intern Med. 2018 Jul 3. pii: 2686987. doi: 10.7326/M17-2740.
     PubMed     Abstract available
     
     
     
118. FRASER A
     Women's Cardiovascular Health After a Hypertensive Disorder of Pregnancy.
     Ann Intern Med. 2018 Jul 3. pii: 2686988. doi: 10.7326/M18-1443.
     PubMed    
     
     
     
119. 
     High Blood Pressure During Pregnancy and Development of Risk Factors for Cardiovascular Disease.
     Ann Intern Med. 2018 Jul 3. pii: 2686989. doi: 10.7326/P18-0008.
     PubMed    
     
     
     June 2018
120. BATES ER
     Review: In CAD, CABG reduced 5-year mortality more than PCI in multivessel but not left main disease.
     Ann Intern Med. 2018;168:JC66.
     PubMed    
     
     
     
121. DEFILIPPIS AP, Trainor P
     When Given a Lemon, Make Lemonade: Revising Cardiovascular Risk Prediction Scores.
     Ann Intern Med. 2018 Jun 5. pii: 2683614. doi: 10.7326/M18-1175.
     PubMed    
     
     
     
122. YADLOWSKY S, Hayward RA, Sussman JB, McClelland RL, et al
     Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk.
     Ann Intern Med. 2018 Jun 5. pii: 2683613. doi: 10.7326/M17-3011.
     PubMed     Abstract available
     
     
     May 2018
123. EBERT BL, Libby P
     Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers.
     Ann Intern Med. 2018 May 29. pii: 2683000. doi: 10.7326/M18-0737.
     PubMed    
     
     
     
124. STAMATELOPOULOS K, Mueller-Hennessen M, Georgiopoulos G, Sachse M, et al
     Amyloid-beta (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study.
     Ann Intern Med. 2018 May 22. pii: 2681795. doi: 10.7326/M17-1540.
     PubMed     Abstract available
     
     
     
125. GOEL A
     Efficacy and safety of ticagrelor were similar in patients with past MI, regardless of multivessel coronary disease.
     Ann Intern Med. 2018;168:JC56.
     PubMed    
     
     
     
126. PERZYNSKI AT, Rothberg MB, Dawson NV, Coulton CJ, et al
     Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position.
     Ann Intern Med. 2018;168:681-682.
     PubMed    
     
     
     
127. SPENCE JD
     Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position.
     Ann Intern Med. 2018;168:680-681.
     PubMed    
     
     
     April 2018
128. CHAMBERLAIN JJ, Johnson EL, Leal S, Rhinehart AS, et al
     Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018.
     Ann Intern Med. 2018 Apr 3. pii: 2677350. doi: 10.7326/M18-0222.
     PubMed     Abstract available
     
     
     March 2018
129. BROWN AF, Liang LJ, Vassar SD, Escarce JJ, et al
     Trends in Racial/Ethnic and Nativity Disparities in Cardiovascular Health Among Adults Without Prevalent Cardiovascular Disease in the United States, 1988 to 2014.
     Ann Intern Med. 2018 Mar 20. pii: 2675356. doi: 10.7326/M17-0996.
     PubMed     Abstract available
     
     
     
130. MENSAH GA
     The Black-White Cardiovascular Health Disparity Is Narrowing, But Not for the Reason You Think.
     Ann Intern Med. 2018 Mar 20. pii: 2675357. doi: 10.7326/M18-0349.
     PubMed    
     
     
     February 2018
131. GRANT PJ, Eagle KA
     Annals for Hospitalists Inpatient Notes - Perioperative Medicine-The Past, Present, and Future of Cardiovascular Risk Assessment and Risk Reduction Strategies.
     Ann Intern Med. 2018;168:HO2-HO3.
     PubMed    
     
     
     January 2018
132. RAVI D, Ghasemiesfe M, Korenstein D, Cascino T, et al
     Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes: A Systematic Review.
     Ann Intern Med. 2018 Jan 23. pii: 2670319. doi: 10.7326/M17-1548.
     PubMed     Abstract available
     
     
     
133. MANCINI GBJ
     Comparison Shopping: Guidelines for Statins for Primary Prevention of Cardiovascular Disease.
     Ann Intern Med. 2018 Jan 2. pii: 2667697. doi: 10.7326/M17-2917.
     PubMed    
     
     
     December 2017
134. LIPSCOMBE LL
     Exenatide did not reduce major cardiovascular outcomes in type 2 diabetes.
     Ann Intern Med. 2017;167:JC67.
     PubMed    
     
     
     
135. SUNDARARAJAN V, Vogrin S
     Comparative Effectiveness of Routine Invasive Coronary Angiography for Managing Unstable Angina.
     Ann Intern Med. 2017;167:836.
     PubMed    
     
     
     
136. OSHIMA Y, Morishima Y, Ono K, Hirano M, et al
     Comparative Effectiveness of Routine Invasive Coronary Angiography for Managing Unstable Angina.
     Ann Intern Med. 2017;167:836.
     PubMed    
     
     
     
137. KOPIN L, Lowenstein C
     Dyslipidemia.
     Ann Intern Med. 2017;167:ITC81-ITC96.
     PubMed     Abstract available
     
     
     November 2017
138. O'DONOGHUE FJ, McDonald CF
     Review: In obstructive sleep apnea, continuous positive airway pressure does not reduce cardiovascular outcomes.
     Ann Intern Med. 2017;167:JC55.
     PubMed    
     
     
     
139. O'DONOGHUE FJ, McDonald CF
     Review: In adults with sleep apnea, positive airway pressure does not reduce cardiovascular events or death.
     Ann Intern Med. 2017;167:JC54.
     PubMed    
     
     
     
140. PICCOLO R, Windecker S
     Low-Dose Aspirin to Reduce the Risk for Myocardial Infarction Among Patients With Coronary Stents Undergoing Noncardiac Surgery.
     Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2954.
     PubMed    
     
     
     
141. GRAHAM MM, Sessler DI, Parlow JL, Biccard BM, et al
     Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery.
     Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2341.
     PubMed     Abstract available
     
     
     
142. NIEUWSMA JA, Williams JW Jr, Namdari N, Washam JB, et al
     Diagnostic Accuracy of Screening Tests and Treatment for Post-Acute Coronary Syndrome Depression: A Systematic Review.
     Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-1811.
     PubMed     Abstract available
     
     
     
143. DAVIDSON KW, Wasson LT, Kronish IM
     Should You Screen for and Manage Depression in Patients With a Recent Acute Coronary Syndrome? Evidence-Based Answers.
     Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2831.
     PubMed    
     
     
     
144. GO AS, Singer DE, Toh S, Cheetham TC, et al
     Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study.
     Ann Intern Med. 2017 Nov 14. doi: 10.7326/M16-1157.
     PubMed     Abstract available
     
     
     
145. ZHANG XL, Zhu QQ, Kang LN, Li XL, et al
     Mid- and Long-Term Outcome Comparisons of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis.
     Ann Intern Med. 2017;167:642-654.
     PubMed     Abstract available
     
     
     October 2017
146. 
     Correction: Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection.
     Ann Intern Med. 2017;167:528.
     PubMed    
     
     
     September 2017
147. DHARMARAJAN K, McNamara RL, Wang Y, Masoudi FA, et al
     Age Differences in Hospital Mortality for Acute Myocardial Infarction: Implications for Hospital Profiling.
     Ann Intern Med. 2017 Sep 26. doi: 10.7326/M16-2871.
     PubMed     Abstract available
     
     
     
148. BAKER DW
     Age-Related Differences in Hospital Quality of Care for Acute Myocardial Infarction: Getting to the Heart of the Matter.
     Ann Intern Med. 2017 Sep 26. doi: 10.7326/M17-2363.
     PubMed    
     
     
     
149. QUINN T
     Review: Real-world use of nonsteroidal antiinflammatory drugs is associated with acute myocardial infarction.
     Ann Intern Med. 2017;167:JC30.
     PubMed    
     
     
     
150. WORSTER A, Kavsak P
     4 hs-cTnI algorithms had high sensitivity and low failure rates for ruling out acute MI in the ED.
     Ann Intern Med. 2017;167:JC35.
     PubMed    
     
     
     
151. WORSTER A, Kavsak P
     High-STEACS Algorithm missed fewer patients with acute MI than the ESC Pathway in the ED.
     Ann Intern Med. 2017;167:JC34.
     PubMed    
     
     
     
152. LOWENSTERN A, Newby LK
     In PCI-treated ACS, switching from aspirin + a newer P2Y12 blocker to aspirin + clopidogrel reduced adverse events.
     Ann Intern Med. 2017;167:JC28.
     PubMed    
     
     
     August 2017
153. RYMER JA, Granger CB
     Review: A single hs-cTnT with a cutpoint < limit of detection plus a nonischemic ECG can rule out acute MI.
     Ann Intern Med. 2017;167:JC23.
     PubMed    
     
     
     July 2017
154. SCHATTNER A
     Patients with new-onset rheumatoid arthritis had increased risk for ischemic and nonischemic heart failure.
     Ann Intern Med. 2017;167:JC8.
     PubMed    
     
     
     April 2017
155. KUSSMAUL III WG
     The Single High-Sensitivity Serum Cardiac Troponin Level: A Significant Advance for Chest Pain Pathways?
     Ann Intern Med. 2017 Apr 18. doi: 10.7326/M17-0919.
     PubMed    
     
     
     February 2017
156. BATES ER
     In left main CAD, PCI with everolimus-eluting stents was noninferior to CABG for death, MI, or stroke at 3 years.
     Ann Intern Med. 2017;166:JC21.
     PubMed    
     
     
     
157. BATES ER
     In left main CAD, CABG reduced major adverse cardiac or cerebrovascular events at 5 years compared with PCI.
     Ann Intern Med. 2017;166:JC20.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: